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Reports that the Bush administration
has expressed an interest in closing the
Guantanamo Bay detainee facility in Cuba
[1], colloquially known in the US as
‘‘Gitmo,’’ could stimulate a new chapter
in US foreign policy. By converting Gitmo
into a biomedical research institute dedi-
cated to combating the diseases of poverty
in the Western Hemisphere, we can tap
into a little known, but highly effective
tradition of vaccine diplomacy that we first
began 50 years ago at the height of the
Cold War [2,3].
In the 1950s, polio epidemics were
ravaging the major urban centers in the
United States and in the Soviet Union.
Children were the chief victims in both
countries. The devastation wreaked by the
polio outbreak spurred the establishment
of new polio research laboratories in
Moscow and in the US at Jonas Salk’s
laboratory in Pittsburgh, Pennsylvania and
at Albert Sabin’s lab in Cincinnati, Ohio.
Not long after the Sputnik launch in
1956, Washington put aside its ideological
differences with the Soviets and permitted
Mikhail Chumakov, the chief virologist at
the Moscow laboratory, to collaborate
with Dr. Sabin’s laboratory to develop
and test a live oral polio vaccine. Three
years after Dr. Chumakov’s historic visit,
the Russians were vaccinating millions of
children using an experimental vaccine
developed in Dr. Sabin’s lab. These initial
Soviet trials provided the basis for the
subsequent licensure of the oral polio
vaccine throughout the US [2,3]. As a
result, almost every American inoculated
against polio after 1963 and prior to 1996
received a vaccine that was developed and
tested through Cold War diplomacy [2,3].
Vaccine diplomacy could be similarly
effective in reaching out to the poorest
people in America’s backyard.
In less than the time it takes to fly from
Washington DC to the West Coast, I can
walk through the public hospitals in
Guatemala, Haiti, Honduras, and Nicar-
agua, and be guaranteed to see children
suffering from protein malnutrition, para-
sitic worm infections, infectious diarrhea,
Chagas disease, and tuberculosis meningi-
tis. Data from the United Nations Chil-
dren’s Fund (UNICEF), World Health
Organization, and the World Bank con-
firm this observation—some of the infant
mortality rates and under-five child mor-
tality rates in Bolivia, Guyana, and Haiti
are as high as those in Botswana, Congo,
Gabon, and Ghana [4]. The rates of
malnutrition (moderate and severe stunt-
ing) in Guatemala, Haiti, and Honduras
rival those in Chad, Somalia, and Zambia
[5]. Indeed, five Latin American nations,
namely Bolivia, Guyana, Haiti, Honduras,
and Nicaragua, stand out for their low
economic growth, low life expectancy, and
high disease rates, presenting a bleak
picture of poverty, malnutrition, and
disease that compares with many regions
of sub-Saharan Africa.
The poorest areas of Latin America and
the Caribbean also stand out for their high
rate of neglected tropical diseases, with
millions or tens of millions of cases of
hookworm and other intestinal worm
infections [6], Chagas disease [7], schisto-
somiasis [8], and dengue [9], and almost
one million cases of lymphatic filariasis
and malaria [9] in the region. In a
previous article published in PLoS Neglected
Tropical Diseases it was pointed out that
many of the neglected tropical diseases
that now occur in Latin America and the
Caribbean were first brought there during
the Middle Passage of the Atlantic slave
trade [10]. In this sense, the region’s
neglected tropical diseases represent a
tragic living legacy of slavery [10].
America has an enormously impressive
track record of developing and testing life-
saving vaccines and drugs. It is therefore
surprising that American leadership in
biomedical sciences and its remarkable
legacy for saving lives abroad has never
been embraced as a meaningful compo-
nent of American foreign policy. The US
spends approximately $100 billion annu-
ally on health research and development,
including $28 billion by the NIH and $57
billion by industry [11,12].
The neglected tropical diseases repre-
sent some of the most important poverty-
promoting disease conditions [13]. By
establishing a center of excellence on the
diseases of poor, at Guantanamo, the
United States Government would directly
address poverty and health disparities in
the worst-off nations in Central and South
America and the Caribbean. Such a
center could conduct translational re-
search to develop new drugs and vaccines
for neglected diseases, possibly in collabo-
ration with research institutes and public
sector pharmaceutical manufacturers in
some of Latin America’s so-called innovative
developing countries, such as Argentina,
Brazil, Cuba, and Mexico [14]. It could
also promote clinical research and take on
the control of some of the more pressing
public health threats in the Caribbean
region, including vector-borne diseases
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vital resource for training physicians,
scientists, and public health experts, and
meet an important demand for training in
applying appropriate technology to global
public health practice [15].
Through a focused initiative on lym-
phatic filariasis and schistosomiasis, a well-
resourced biomedical institution located at
Guantanamo could lead a path to elimi-
nate these scourges from the Caribbean
region [16] and forever wipe out an
important element of slavery’s legacy
[10]. The facility could even take on some
neglected tropical diseases that remain
important yet often hidden public health
problems among the economically disad-
vantaged and under-represented minori-
ties living in the US, such as cysticercosis,
dengue, leptospirosis, toxocariasis, and
congenital cytomegalovirus infection and
toxoplasmosis [17].
It is a moral outrage that a wealthy
country like the United States allows its
closest neighbors to suffer from some of
the world’s worst levels of disease, poverty,
and malnutrition. Reinventing Gitmo to
address our hemisphere’s most pressing
neglected health problems could help
change America’s reputation and legacy
in the region. The US has previously
supported covert military operations and
encouraged military coups in the Americas
[18], while the US Army continues to
interrogate terrorist suspects at Gitmo
(‘‘We interrogate seven days a week,
24 hours a day,’’ a US general based at
Gitmo told CBS news [19]). By transform-
ing Gitmo from a detainee facility to a
center for research on the diseases of
poverty, the US would show that it
sincerely wants to address the Millennium
Development Goals in Latin America and
the Caribbean [13], and ultimately make
things better for the next generation of all
Americans.
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